Affiliation:
1. Centre Hospitalier Universitaire de Rennes
2. Univ Rennes, CHU Rennes, Inserm, Irset (Institut de recherche en santé
3. Univ Rennes, CHU Rennes, Inserm, Institut Numecan (Nutrition, métabolismes et cancer) -UMR_S 1317
Abstract
Abstract
Background: The dissemination of clinical trial results is an important scientific and ethical endeavour. This survey of completed interventional studies in a French academic center describes their reporting status.
Methods: We explored all interventional studies sponsored by Rennes University Hospital identified on the French Open Science Monitor which tracks trials registered on EUCTR or clinicaltrials.gov, and provides an automatic assessment of the reporting of results. For each study, we ascertained the actual reporting of results using systematic searches on the hospital internal database, bibliographic databases (Google Scholar, PubMed), and by contacting all principal investigators (PIs). We describe several features (including total budget and numbers of trial participants) of the studies that did not report any results.
Results: The French Open Science Monitor identified 93 interventional studies, among which 10 (11%) reported results. In contrast, our survey identified 36 studies (39%) reporting primary analysis results and an additional 18 (19%) reporting results for secondary analyses (without results for their primary analysis). The overall budget for studies that did not report any results was estimated to be €5,051,253 for a total of 6,735 trial participants. The most frequent reasons for the absence of results reported by PIs were lack of time for 18 (42%), and logistic difficulties (e.g. delay in obtaining results or another blocking factor) for 12 (28%). An association was found between non-publication and negative results (adjusted Odds Ratio = 4.70, 95% Confidence Interval [1.67;14.11]).
Conclusions: Even allowing for the fact that automatic searches underestimate the number of studies with published results, the level of reporting was disappointingly low. This amounts to a waste of trial participants' implication and money. Corrective actions are needed.
Registration: 10.17605/OSF.IO/Q5HCS
Publisher
Research Square Platform LLC
Reference28 articles.
1. WMA - The World Medical Association-WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects [Internet]. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.
2. WHO Statement on public disclosure of clinical trial results [Internet]. Available from: https://www.who.int/news/item/09-04-2015-japan-primary-registries-network.
3. Registration of published randomized trials: a systematic review and meta-analysis;Trinquart L;BMC Med,2018
4. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013;Viergever RF;BMJ Open,2015
5. Posting of clinical trial summary results in European Clinical Trials Database. (EudraCT) to become mandatory for sponsors as of 21 July 2014 | European Medicines Agency [Internet]. Available from: https://www.ema.europa.eu/en/news/posting-clinical-trial-summary-results-european-clinical-trials-database-eudract-become-mandatory-sponsors-21-july-2014.